DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.33−0.33 (-3.42%)
Close on Nov 12, 2026Market cap $503.13MP/E –Yield –
DiaMedica Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
DiaMedica Therapeutics's price to book ratio was 13.6× on Nov 11, 2026, against 8.7× a year earlier. Over the last 5 years it ranged from 0.8× to 13.6×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.6× | +5.6 |
| 2025 | Dec 31, 2025 | 8.0× | +3.2 |
| 2024 | Dec 31, 2024 | 4.8× | +2.9 |
| 2023 | Dec 29, 2023 | 1.9× | +0.7 |
| 2022 | Dec 30, 2022 | 1.2× | −0.9 |
| 2021 | Dec 31, 2021 | 2.1× | −4.3 |
| 2020 | Dec 31, 2020 | 6.4× | +0.4 |
| 2019 | Dec 31, 2019 | 6.0× | −17.2 |
| 2018 | Dec 31, 2018 | 23.2× | – |
See a number that looks wrong?